The Tang Prize Partners with IUBMB to Facilitate Education in Biopharmaceutical Science

Taipei, Taiwan, Aug. 30, 2017 (GLOBE NEWSWIRE) — After the signing of a memorandum of cooperation that establishes a 10-year partnership with the Experimental Biology, the Tang Prize Foundation has taken another step forward in promoting the advancement of biopharmaceutical science education by forming another partnership with the International Union of Biochemistry and Molecular Biology.

IUBMB plays a significant role in uniting researchers and scientists in the fields of biochemistry and molecular biology from 77 countries across four continents. Andrew H. J. Wang is a world-renowned researcher in the field who currently serves as the president-elect of the IUBMB and is also the academician of the Academia Sinica.  He acted as a go-between to facilitate a nine-year partnership project between the Tang Prize and the IUBMB.

On Sept. 6–8, Wang will participate in the “New Horizons in Biochemistry & Molecular Biology Education” conference hosted by the Weizmann Institute of Science, one of the world’s leading science research institutions in Israel that ranked sixth in the 2017 Nature Innovation Index. Co-organized by WIS, IUBMB, and the Federation of European Biochemical Societies, this educational conference aims to provide a think-tank setting that can bring inspiration to the teaching approach in the subjects relating to biochemistry and molecular biology. The Tang Prize will support outstanding young scientists to attend the conference along with Wang, which in turn can provide them with an opportunity to introduce their research and establish international network.

The IUBMB-FEBS conference on education is followed by the FEBS 2017 Congress, which will take place on Sept. 10–14 at the International Conference Center in Jerusalem. This year, the congress will focus on topics surrounding the application of CRISPR/Cas9. Feng Zhang – a 2016 Tang Prize laureate and associate professor at the MIT Departments of Brain and Cognitive Sciences and Biological Engineering – is hosting a Tang Prize/IUBMB lecture on Sept. 12 with the topic “From Microbial Immunity to Genome Editing.” Zhang was awarded the 2016 Tang Prize in Biopharmaceutical Science along with Emmanuelle Charpentier and Jennifer Doudna “for the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment.”

Read the full press release.

Categories: Press releases

Leave a Reply

Your email address will not be published. Required fields are marked *